http://rdf.ncbi.nlm.nih.gov/pubchem/reference/10198581

Outgoing Links

Predicate Object
contentType Journal Article
endingPage 1123
issn 2218-6751
2226-4477
issueIdentifier 4
pageRange 1112-1123
publicationName Translational Lung Cancer Research
startingPage 1112
bibliographicCitation Xie D, Wang TT, Huang SJ, Deng JJ, Ren YJ, Yang Y, Wu JQ, Zhang L, Fei K, Sun XW, She YL, Chen C. Radiomics nomogram for prediction disease-free survival and adjuvant chemotherapy benefits in patients with resected stage I lung adenocarcinoma. Transl Lung Cancer Res. 2020 Aug;9(4):1112–23. PMID: 32953490; PMCID: PMC7481634.
creator http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_5c0bcf024e506be12fcb4af0f62148c7
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_2968d54ce68b26f6081d1499c29e5d15
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_628448ae9ec8df31154530ae1287704f
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f05ab3c9fb8b7eca3a50875bae1e3ce2
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_467d45f563357ae54adb1322ac889ca4
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_645bd5c7c983695f685c121707d165d3
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b6b1715b1d6d09869b9bb6a543d25a7b
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_1a603bfc24a58d0c1b28eb88291aa9ad
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e659e70f32a94d5dab44a36f9e0ef203
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_38c59da49cddb6684821073f01432c88
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_47885ff120b201f5f1728757746718ef
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_99a5eacf7c847d515ffc097bdc613148
date 202008
identifier https://pubmed.ncbi.nlm.nih.gov/PMC7481634
https://pubmed.ncbi.nlm.nih.gov/32953490
https://doi.org/10.21037/tlcr-19-577
isPartOf https://portal.issn.org/resource/ISSN/2226-4477
https://portal.issn.org/resource/ISSN/2218-6751
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/43494
language English
source https://www.crossref.org/
https://pubmed.ncbi.nlm.nih.gov/
title Radiomics nomogram for prediction disease-free survival and adjuvant chemotherapy benefits in patients with resected stage I lung adenocarcinoma
discussesAsDerivedByTextMining http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10509
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8607
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID6650

Total number of triples: 35.